Literature DB >> 2182721

Cutaneous IgA deposits in bullous diseases function as ligands to mediate adherence of activated neutrophils.

J D Hendrix1, K L Mangum, J J Zone, W R Gammon.   

Abstract

Linear IgA bullous dermatosis and dermatitis herpetiformis are inflammatory subepidermal blistering diseases characterized by IgA deposits at the cutaneous epithelial basement membrane and in dermal papillae, respectively. Inflammation in both disorders localizes to sites of IgA deposition and is characterized by a predominance of neutrophils. From these observations we postulate that IgA deposits in both diseases may contribute to the recruitment and/or localization of neutrophils. In this study we examined the ability of in vitro and in vivo bound IgA anti-basement membrane autoantibodies from patients with linear IgA bullous dermatosis and in vivo bound IgA deposits in dermal papillae from patients with dermatitis herpetiformis to mediate adherence of neutrophils stimulated by granulocyte macrophage colony-stimulating factor. The study showed that stimulated neutrophils adhered to basement membranes and dermal papillae containing IgA deposits. Adherence was IgA anti-basement membrane antibody concentration dependent and correlated with the immunofluorescence staining intensity of IgA deposits in dermal papillae. Adherence to IgA deposits but not IgG deposits could be inhibited by purified exogenous secretory IgA but not IgG and adherence to IgG deposits could be inhibited by purified exogenous IgG but not secretory IgA. These results provide direct experimental evidence that cutaneous IgA deposits in linear IgA bullous dermatosis and dermatitis herpetiformis can function as ligands for neutrophil adherence and have a role in the localization of inflammation in these disorders.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2182721     DOI: 10.1111/1523-1747.ep12876246

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

Review 1.  Cutaneous manifestations in celiac disease.

Authors:  L Abenavoli; I Proietti; L Leggio; A Ferrulli; L Vonghia; R Capizzi; M Rotoli; P L Amerio; G Gasbarrini; G Addolorato
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

Review 2.  Recent advances in dermatitis herpetiformis.

Authors:  Kimiko Nakajima
Journal:  Clin Dev Immunol       Date:  2012-07-02

3.  Mediators of mast cells in bullous pemphigoid and dermatitis herpetiformis.

Authors:  Agnieszka Zebrowska; Malgorzata Wagrowska-Danilewicz; Marian Danilewicz; Olga Stasikowska-Kanicka; Lilianna Kulczycka-Siennicka; Anna Wozniacka; Elzbieta Waszczykowska
Journal:  Mediators Inflamm       Date:  2014-10-21       Impact factor: 4.711

4.  Tissue Factor in Dermatitis Herpetiformis and Bullous Pemphigoid: Link between Immune and Coagulation System in Subepidermal Autoimmune Bullous Diseases.

Authors:  Agnieszka Zebrowska; Malgorzata Wagrowska-Danilewicz; Marian Danilewicz; Joanna Wieczfinska; Ewa Pniewska; Michal Zebrowski; Elzbieta Waszczykowska; Anna Wozniacka; Makandjou-Ola Eusebio; Miroslawa Pietruczuk; Rafal Pawliczak
Journal:  Mediators Inflamm       Date:  2015-12-29       Impact factor: 4.711

5.  IL-17 expression in dermatitis herpetiformis and bullous pemphigoid.

Authors:  Agnieszka Zebrowska; Malgorzata Wagrowska-Danilewicz; Marian Danilewicz; Olga Stasikowska-Kanicka; Anna Cynkier; Anna Sysa-Jedrzejowska; Elzbieta Waszczykowska
Journal:  Mediators Inflamm       Date:  2013-07-21       Impact factor: 4.711

6.  IgG, IgM, and IgA antinuclear antibodies in discoid and systemic lupus erythematosus patients.

Authors:  Sheridan A Jost; Lin-Chiang Tseng; Loderick A Matthews; Rebecca Vasquez; Song Zhang; Kim B Yancey; Benjamin F Chong
Journal:  ScientificWorldJournal       Date:  2014-03-05

Review 7.  Immunopathology and molecular diagnosis of autoimmune bullous diseases.

Authors:  Sidonia Mihai; Cassian Sitaru
Journal:  J Cell Mol Med       Date:  2007 May-Jun       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.